Filing Flows › ENvue Medical (FEED) › Q2 2026
ENvue Medical (FEED) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 17, 2026
ENvue Medical (FEED) reported revenue of $239K for the second quarter 2026 (Q2 2026), -52% from a year earlier and -63% from the quarter before.
ENvue Medical, Q2 2026: revenue $239K (-52% year over year), net loss $4.9M, operating cash flow −$2.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $239K | -63% | -52% |
| Operating profit | −$5.5M | — | — |
| Net earnings | −$4.9M | — | — |
| Operating cash flow | −$2.7M | — | — |
What changed
Revenue was $239K in Q2 2026, down 52% year over year and down 63% from the previous quarter. ENvue was the largest line at 77% of revenue. Nano Vibronix lost $390K year over year (down 88%), 153% of the total change.
Operating costs exceeded revenue by $5.5M, an operating margin of -2290.4%. Total costs grew 28% against a revenue fall of 52%. The fastest-growing cost line was Sales & marketing (+78%). The quarter ended with a net loss of $4.9M, wider than the previous quarter's $3.8M loss.
Operating cash flow was −$2.7M. Non-cash charges added back $219K of depreciation and amortization. Working capital and other items added $2.0M. Capital expenditures of $27K exceeded it, leaving free cash flow of −$2.7M.
Questions
What was ENvue Medical's revenue in the second quarter 2026?
ENvue Medical (FEED) reported revenue of $239K for the second quarter 2026 (Q2 2026), -52% from a year earlier and -63% from the quarter before.
Source: ENvue Medical 10-Q on SEC EDGAR.